Sinovac Biotech Ltd (SVA):製薬・医療:M&Aディール及び事業提携情報

【英語タイトル】Sinovac Biotech Ltd (SVA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

GlobalDataが出版した調査資料(DATA904C12324)・商品コード:DATA904C12324
・発行会社(調査会社):GlobalData
・発行日:2018年12月
・ページ数:31
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥27,250見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥54,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥81,750見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000を加算
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

Summary
Sinovac Biotech Ltd (Sinovac Biotech) is a biopharmaceutical company that develops, manufactures and commercializes vaccines. The company’s products comprise healive, bilive, anflu, panflu and panflu, among others. Its healive is an inactivated hepatitis A vaccine. Sinovac Biotech’s bilive is a combined inactivated hepatitis A and B vaccine. Sinovac Biotech’s anflu is a split viron influenza vaccine. The company’s panflu is a vaccine against the H5N1 influenza vaccine. Its panflu is a vaccine against the influenza A H1N1 virus. The company conducts research to develop novel vaccines for infectious diseases such as SARS, avian influenza, H1N1 influenza and hand foot and mouth disease, among others. It markets its products in China and abroad. Sinovac Biotech is headquartered in Beijing, China.

Sinovac Biotech Ltd (SVA) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Sinovac Biotech Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Sinovac Biotech Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Sinovac Biotech Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Sinovac Biotech Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Sinovac Biotech Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Sinovac Biotech Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Licensing Agreements 10
Sinovac Biotech Enters Into Licensing Agreement With Intravacc For Sabin Inactivated Polio Vaccine 10
Equity Offering 11
Sinovac Biotech Raises USD86.7 Million in Private Placement of Shares 11
Acquisition 13
Shandong Sinobioway Biomedicine to Acquire Sinovac Biotech 13
Sinovac Biotech Ltd – Key Competitors 15
Sinovac Biotech Ltd – Key Employees 16
Sinovac Biotech Ltd – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Recent Developments 18
Financial Announcements 18
Nov 08, 2018: Sinovac reports unaudited first half of 2018 financial results 18
Dec 01, 2017: Sinovac Reports Unaudited First Half of 2017 Financial Results 20
Corporate Communications 22
Mar 05, 2018: Sinovac Announces Re-Election of All Directors at Annual General Meeting 22
Nov 08, 2017: Sinovac Biotech Announces Request Hearing before Nasdaq 23
Legal and Regulatory 24
Jun 26, 2018: Sinovac Files Motion for Summary Judgment on Rights Agreement in Delaware Chancery Court 24
Product News 25
04/30/2018: Sinovac Forced to Plan to Destroy Bacterial Seeds intended for Pneumo Vaccine Production and Postpone Site Inspection 25
Other Significant Developments 26
Apr 23, 2018: Sinovac Resumes Production and Operation at Sinovac Beijing’s Quality Assurance Department 26
Mar 05, 2018: Sinovac Announces Enhancement of Corporate Governance and Management of China Operating Entity 27
Jan 31, 2018: An Open Letter From Sinobioway Consortium to All Shareholders of Sinovac Biotech 28
Appendix 31
Methodology 31
About GlobalData 31
Contact Us 31
Disclaimer 31

List of Tables
Sinovac Biotech Ltd, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Sinovac Biotech Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Sinovac Biotech Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Sinovac Biotech Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Sinovac Biotech Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Sinovac Biotech Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Sinovac Biotech Enters Into Licensing Agreement With Intravacc For Sabin Inactivated Polio Vaccine 10
Sinovac Biotech Raises USD86.7 Million in Private Placement of Shares 11
Shandong Sinobioway Biomedicine to Acquire Sinovac Biotech 13
Sinovac Biotech Ltd, Key Competitors 15
Sinovac Biotech Ltd, Key Employees 16
Sinovac Biotech Ltd, Subsidiaries 17

List of Figures
Sinovac Biotech Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Sinovac Biotech Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Sinovac Biotech Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Sinovac Biotech Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Sinovac Biotech Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Sinovac Biotech Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Sinovac Biotech Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Sinovac Biotech Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★調査レポート[Sinovac Biotech Ltd (SVA):製薬・医療:M&Aディール及び事業提携情報] (コード:DATA904C12324)販売に関する免責事項を必ずご確認ください。
★調査レポート[Sinovac Biotech Ltd (SVA):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆